Created at Source Raw Value Validated value
Oct. 26, 2020, 7:26 a.m. eu

[{"arm_notes": null, "treatment_id": null, "treatment_name": "ANAKINRA", "treatment_type": "Immunomodulator", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": null, "treatment_id": null, "treatment_name": "TOCILIZUMAB", "treatment_type": "Monoclonal antibodies", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": null, "treatment_id": null, "treatment_name": "TOCILIZUMAB", "treatment_type": "Monoclonal antibodies", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "New Type treatment : Siltuximab", "treatment_id": 1198, "treatment_name": "Siltuximab", "treatment_type": "Interleukin inhibitors", "pharmacological_treatment": "Pharmacological treatment"}]

[{"arm_notes": null, "treatment_id": 83, "treatment_name": "Anakinra", "treatment_type": "Interleukin inhibitors", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "20 mg/ml", "treatment_id": 1299, "treatment_name": "Tocilizumab", "treatment_type": "Interleukin inhibitors", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "162 mg", "treatment_id": 1299, "treatment_name": "Tocilizumab", "treatment_type": "Interleukin inhibitors", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 1198, "treatment_name": "Siltuximab", "treatment_type": "Interleukin inhibitors", "pharmacological_treatment": "Pharmacological treatment"}]